Enjoy complimentary customisation on priority with our Enterprise License!
The in-vitro diagnostics instruments market size is forecast to increase by USD 52.9 billion at a CAGR of 9.29% between 2024 and 2028. The market is experiencing significant growth due to several key trends. The aging population is a major driver, as the increasing prevalence of chronic diseases among older individuals necessitates frequent diagnostic testing. Additionally, there are potential opportunities for physician office laboratories (POLs) to expand their diagnostic capabilities and improve patient care, thereby increasing instrument sales. However, strained laboratory budgets and lowering reimbursements pose challenges to market growth. To mitigate these challenges, market participants are focusing on developing cost-effective and high-value instruments that offer faster turnaround times and improved accuracy. Overall, the market is expected to witness steady growth in the coming years, driven by these trends and the ongoing demand for accurate and efficient diagnostic solutions.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.